Product examples
These examples show how monitoring, cited answers, exports, and commissioned research are delivered.
01 / Peptide Watch
Each entry names what changed, why it matters, and where to inspect the underlying record.
New source: the TRANSCEND-T2D-1 phase 3 publication. Previous state: the human evidence section relied on phase 2 obesity and diabetes trials. Review result: the diabetes evidence now includes a controlled late-stage trial, while Retatrutide remains investigational and has no final prescribing label.
02 / Ask Peptides.media
Answers stay tied to the article and original records, so the supporting evidence is visible.
What does human research show for BPC-157 and knee or tendon recovery?
Human evidence is sparse. The strongest clinical item in the BPC-157 article is a small retrospective knee-pain chart review without a control group. It reported patient improvement, but it did not establish effectiveness for tendon injuries or show how the result would transfer to other products and routes.12
A separate two-person intravenous pilot measured short-term tolerability, not injury recovery.3
03 / Source Packet
A packet keeps the readable article, evidence labels, use patterns, and reference data together.
Included
Available formats
04 / Research Desk
These samples show the structure, source handling, and level of detail available for commissioned work.
Choose a format